Abstract
Purpose
An alternative option to human chorionic gonadotropin (hCG) is GnRH agonist (GnRH-a) for ovulation trigger in intrauterine insemination (IUI) cycles. This study aims to compare the efficacy of GnRH-a with hCG in women with history of follicular–endometrial asynchrony after clomiphene in IUI cycles.
Methods
This prospective observational study recruited 631 women with unexplained infertility and follicular–endometrial asynchrony (follicle ≥ 18 mm, endometrial thickness (ET) < 7 mm) in previous two failed clomiphene/IUI cycles. Overall 27 patients with synchronized follicular–endometrial relationship and 49 women with persistent ET < 7 mm and/or follicle > 26 mm were excluded. Remaining women (n = 555) were divided into two groups: Group A (n = 285) received GnRH-a and Group B (n = 270) received hCG ovulation trigger. Finally, 513 patients, who underwent IUI, were analysed.
Results
Cancellation due to luteinized unruptured follicle was more in hCG group (P = 0.01). Higher clinical pregnancies (10.33 vs. 4.96%, P = 0.03) and live birth rates (8.86 vs. 4.13%, P = 0.03) were noted with GnRH-a trigger. Miscarriage rate was comparable in both the groups (10.71 and 16.67% in Group A and Group B, respectively).
Conclusion
In unexplained infertility, GnRH agonist is an useful alternative for triggering ovulation in women with follicular–endometrial asynchrony following clomiphene induction.
Similar content being viewed by others
References
Mitwally MF, Abdel-Razeq S, Casper RF (2004) Human chorionic gonadotropin administration is associated with high pregnancy rates during ovarian stimulation and timed intercourse or intrauterine insemination. Reprod Biol Endocrinol 2:55–62
Andersen AG, Als-Nielsen B, Hornnes PJ, Franch Andersen L (1995) Time interval from human chorionic gonadotrophin (HCG) injection to follicular rupture. Hum Reprod 10(12):3202–3205
Farhi J, Orvieto R, Gavish O, Homburg R (2010) The association between follicular size on human chorionic gonadotropin day and pregnancy rate in clomiphene citrate treated polycystic ovary syndrome patients. Gynecol Endocrinol 26:546–548
Qublan H, Amarin Z, Nawasreh M, Diab F, Malkawi S, Al-Ahmad N, Balawneh M (2006) Luteinized unruptured follicle syndrome: incidence and recurrence rate in infertile women with unexplained infertility undergoing intrauterine insemination. Hum Reprod 21(8):2110–2113
Dickey RP, Holtkamp DE (1996) Development, pharmacology and clinical experience with clomiphene citrate. Hum Reprod Update 2:483–506
Nakamura Y, Ono M, Yoshida Y, Sugino N, Ueda K, Kato H (1997) Effects of clomiphene citrate on the endometrial thickness and echogenic pattern of the endometrium. Fertil Steril 67:256–260
Homburg R (2005) Clomifene citrate—end of an era? Hum Reprod 20:2043–2051
Friedler S, Schenken JG, Herman A, Lewin A (1996) The role of ultrasonography in the evaluation of endometrial receptivity following reproductive treatments: a critical review. Hum Reprod Update 4:323–335
Dickey RP, Olar TT, Taylor SN, Curole DN, Matulich EM (1993) Relationship of endometrial thickness and pattern to fecundity in ovulation induction cycles; effect of clomiphene citrate alone and with human menopausal gonadotropins. Fertil Steril 59:756–760
Lewis V, Queenan J Jr, Hoeger K, Stevens J, Guzick DS (2006) Clomiphene citrate monitoring for intrauterine insemination timing: a randomized trial. Fertil Steril 85(2):401–406
Humaidan P, Papanikolaou EG, Tarlatzis BC (2009) GnRHa to trigger final oocyte maturation: a time to reconsider. Hum Reprod 24(10):2389–2394
Casper RF (2015) Basic understanding of gonadotropin-releasing hormone–agonist triggering. Fertil Steril 103(4):867–869
Shapiro BS, Andersen CY (2015) Major drawbacks and additional benefits of agonist trigger–not ovarian hyperstimulationsyndrome related. Fertil Steril 103(4):874–878
Youssef MA, Van der Veen F, Al-Inany HG, Mochtar MH, Griesinger G, Nagi Mohesen M, Aboulfoutouh I, van Wely M (2014) Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology. Cochrane Database Syst Rev 31(10):CD008046
Gonen Y, Balakier H, Powell W, Casper RF (1990) Use of GnRH agonist to trigger follicular maturation for in vitro fertilization. J Clin Endocrinol Metab 71:918–922
Shalev E, Geslevich Y, Matilsky M, Ben-Ami M (1995) Induction of pre-ovulatory gonadotrophin surge with gonadotrophin-releasing hormone agonist compared to pre-ovulatory injection of human chorionic gonadotrophins for ovulation induction in intrauterine insemination treatment cycles. Hum Reprod 10(9):2244–2247
Scott RT, Bailey SA, Kost ER, Neal GS, Hofmann GE, Illions EH (1994) Comparison of leuprolide acetate and human chorionic gonadotrophin for the induction of ovulation in clomiphene citrate stimulated cycles. Fertil Steril 61(5):872–879
Hutchison JS, Nelson PB, Zeleznik AJ (1986) Effects of different gonadotrophin pulse frequencies on corpus luteum function during the menstrual cycle of rhesus monkeys. Endocrinology 119(5):1964–1971
Cantineau AE, Janssen MJ, Cohlen BJ, Allersma T (2014) Synchronised approach for intrauterine insemination in subfertile couples. Cochrane Database Syst Rev 21(12):CD006942
Lanzone A, Fulghesu AM, Apa R, Caruso A, Mancuso S (1989) LH surge induction by GnRH agonist at the time of ovulation. Gynecol Endocrinol 3(3):213–220
Farag AH, El-deen MHN, Hassan RM (2015) Triggering ovulation with gonadotropin-releasing hormone agonist versus human chorionic gonadotropin in polycystic ovarian syndrome. A randomized trial. Middle East Fertil Soc J 20:217–223
Schmidt-Sarosi C, Kaplan DR, Sarosi P, Essig MN, Licciardi FL, Keltz M, Levitz M (1995) Ovulation triggering in clomiphene citrate-stimulated cycles: human chorionic gonadotropin versus a gonadotropin releasing hormone agonist. J Assist Reprod Genet 12(3):167–174
Kucuk T (2008) Intrauterine insemination: is the timing correct? J Assist Reprod Genet 25(8):427–430
Romeu A, Monzó A, Peiró T, Diez E, Peinado JA, Quintero LA (1997) Endogenous LH surge versus hCG as ovulation trigger after low-dose highly purified FSH in IUI: a comparison of 761 cycles. J Assist Reprod Genet 14(9):518–524
Acknowledgements
We would like to thank DR. Pratip Chakraborty for statistical help.
Author information
Authors and Affiliations
Contributions
SB: Protocol development, data analysis, manuscript writing and editing. AC: Data collection, manuscript writing. SS: Protocol development, data analysis, manuscript writing and editing. SS: Data collection, manuscript writing. IS: Manuscript writing and editing. BC: Protocol development and manuscript editing.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Ethical approval
Ethical approval was obtained from the institutional review board (IRM/IEC/BNC-IHP/46).
Research involving human participants and/or animals
This article does not contain any studies with animals performed by any of the authors.
Informed consent
Written informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Bathwal, S., Chakravarty, A., Sharma, S. et al. Efficacy of GnRH agonist trigger in women having history of follicular–endometrial asynchrony with clomiphene/IUI cycles in unexplained infertility. Arch Gynecol Obstet 298, 427–432 (2018). https://doi.org/10.1007/s00404-018-4834-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-018-4834-1